About | ICE
Advisory Committee | ICE Operating
Committee | FAQs | Service
Centers | Related
Research
With a generous gift from an anonymous donor,
the Institute for Cell Engineering was created at The Johns Hopkins University
School of Medicine in January 2001, its purpose to focus and strengthen
research efforts whose goal at one time likely would have been described
as science fiction. ICE supports and houses scientists working to understand
how cells' fates are determined and to harness that information in order
to select, modify and reprogram human cells. While basic research will
be the hallmark of ICE science, the ultimate goal is to mold engineered
human cells into therapeutic transplants for a wide range of currently
devastating diseases, including Parkinson's disease, Lou Gehrig's disease
or amyotrophic lateral sclerosis (ALS), diabetes and heart failure.
After the 1998 announcements by researchers at Johns
Hopkins and the University of Wisconsin of their independent and successful
isolation and culturing of human pluripotent stem cells -- primitive "precursor" cells
capable of becoming virtually any of the cell types found in the body --
the world has waited wide-eyed for a veritable revolution in medicine. Since
the cells' discovery, researchers have been studying how these cells "decide" what
to become, a key step in capturing their potential to rebuild tissues lost
to disease.
ICE was envisioned to provide an unprecedented
academic infrastructure and environment to accelerate the pace of discovery
in a variety of stem cell related fields, leading the world in the effort
to realize the potential of stem cells in medicine. Today, ICE researchers
are studying many types of cells for clues to differentiation -- how cells
specialize -- and insight into how organisms as complex as mice and humans
develop so precisely.
The Institute occupies two floors of laboratories,
offices and resource facilities in the new, state-of-the-art research building
on Broadway, completed in early 2004. ICE has already launched core resource
facilities, recruited new faculty, formed four primary research programs,
awarded pilot funds and established affiliated research programs.
Among ICE's current activities is a collaborative effort to establish a premier
proteomics facility at Johns Hopkins. On Sept. 30, 2002, Johns Hopkins received
more than $18 million from the National Heart, Lung and Blood Institute (NHLBI)
to establish the Johns Hopkins NHLBI Proteomics Center, one of 10 such centers
nationwide. ICE has provided $2 million to the new center, matching the "infrastructure" funds
from the NHLBI contract.
|